FOXO1 and acute lymphoblastic leukemia: Intriguingly, we found that lower FOXO1 expression was significantly associated with glucocorticoid resistance, a crucial component in the ALL therapy, which may explain how lower FOXO1 expression contributes to higher MRD levels and relapse.